Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: A PET/[11C]raclopride study in healthy men

Neuropsychopharmacology

Volumn 27, Issue 6, 2002, Pages 1027-1035

  Leyton, Marco ^a   Boileau, Isabelle ^a,b   Benkelfat, Chawki ^a,b   Diksic, Mirko ^b   Baker, Glen ^c   Dagher, Alain ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Addiction; Nucleus accumbens; Reinforcement; Reward

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; DOPAMINE; PLACEBO; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ALERTNESS; ANXIETY; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE; BRAIN MAPPING; CAUDATE NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DATA ANALYSIS; DOPAMINE RELEASE; DRUG BINDING; EUPHORIA; EXPLORATORY BEHAVIOR; EXTRACELLULAR SPACE; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; MALE; MOOD; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; REWARD; STATISTICAL SIGNIFICANCE;

ADULT; AMPHETAMINE; ANALYSIS OF VARIANCE; BEHAVIOR, ADDICTIVE; CORPUS STRIATUM; DOPAMINE; EXPLORATORY BEHAVIOR; EXTRACELLULAR SPACE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; RACLOPRIDE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036897933     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00366-4     Document Type: Article

References (61)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 9:1986;357-381.
2. Angrist B., Corwin J., Bartlik B., Cooper T. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry. 22:1987;1357-1368.
3. Aronson S.C., Black J.E., McDougle C.J., Scanley B.E., Jatlow P., Kosten T.R., Heninger G.R., Price L.H. Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berl). 119:1995;179-185.
4. Aston J.A., Gunn R.N., Worsley K.J., Ma Y., Evans A.C., Dagher A. A statistical method for the analysis of positron emission tomography neuroreceptor ligand data. Neuroimage. 12:2000;245-256.
5. Bond A., Lader M. The use of analog scales in rating subjective feelings. Br J Med Psychol. 47:1974;211-218.
6. Brauer L.H., De Wit H. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav. 56:1997;265-272.
7. Breier A., Su T.-P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations. Evidence from a novel positron emission tomography method Proc Natl Acad Sci USA. 94:1997;2569-2574.
8. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., Kantor H.L., Gastfriend D.R., Riorden J.P., Mathew R.T., Rosen B.R., Hyman S.E. Acute effects of cocaine on human brain activity and emotion. Neuron. 19:1997;591-611.
9. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 156:1999;11-18.
10. Cloninger C.R. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 44:1987;573-588.
11. Cloninger C.R., Przybeck T.R., Svrakic D.M. The Tridimensional Personality Questionnaire. U.S. normative data Psych Rep. 69:1991;1047-1057.
12. Collins D.L., Neelin P., Peter T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 18:1994;192-205.
13. Cousins M.S., Stamat H.M., de Wit H. Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology (Berl). 157:2001;243-253.
14. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 85:1988;5274-5278.
15. Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., Price J.L., Mathis C.A. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry. 49:2001;81-96.
16. 11C]raclopride. combined PET-microdialysis studies J Cereb Blood Flow Metab. 17:1997;932-942.
17. Evans A.C., Marrett S., Neelin P., Collins L., Worsley K., Dai W., Milot S., Meyer E., Bub D. Anatomical mapping of functional activation in stereotactic coordinate space. Neuroimage. 1:1992;43-53.
18. Fibiger H.C. Neurobiology of depression. focus on dopamine Fratta W., Pani L., Serra G. Depression and Mania. From Neurobiology to Treatment:1995;1-17 Raven Press, New York.
19. First M.B., Spitzer R.I., Gibbon M. Axis I Disorders. 1995;New York State Psychiatric Institute, New York.
20. Gabel S., Stallings M.C., Schmitz S., Young S.E., Fulker D.W. Personality dimensions and substance misuse. relationship in adolescents, mothers and fathers Am J Addict. 8:1999;101-113.
21. Gerra G., Zaimovic A., Timpano M., Zambelli U., Delsignore R., Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 25:2000;479-496.
22. Grant S., London E.D., Newlin D.B., Villemange V.L., Liu X., Contoreggi C., Phillips R.L., Kimes A.S., Margolin A. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA. 93:1996;12040-12045.
23. Gunn R.N., Lammertsma A.A., Hume S.P., Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 6:1997;279-287.
24. Haber S.N., McFarland N.R. The concept of the ventral striatum in nonhuman primates. Ann NY Acad Sci. 877:1999;33-48.
25. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology. 11:1994;245-256.
26. Hill H.E., Haertzen C.A., Wolbach A.B. Jr., Miner E.J. The addiction research center inventory. Appendix I. Items comprising empirical scales for seven drugs. II. Items which do not discriminate placebo from any drug condition Psychopharmacologia. 4:1963;184-205.
27. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., Justice J.B. Jr. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse. 9:1991;121-128.
28. Howard M.O., Kivlahan D., Walker R.D. Cloninger's tridimensional theory of personality and psychopathology. applications to substance use disorders J Stud Alcohol. 58:1997;48-66.
29. Jaffe J.H., Cascella N.G., Kumor K.M., Sherer M.A. Cocaine-induced cocaine craving. Psychopharmacology (Berl). 97:1989;59-64.
30. Kilts C.D., Schweitzer J.B., Quinn C.K., Gross R.E., Faber T.L., Muhammad F., Ely T.D., Hoffman J.M., Drexler K.P.G. Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry. 58:2001;334-341.
31. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci. 9:1989;2051-2065.
32. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques. a critical review J Cereb Blood Flow Metab. 20:2000;423-451.
33. Laruelle M., Abi-Dargham A., van Dyck C.H., Rosenblatt W., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Charney D.S., Hoffer P.B., Kung H.F., Innis R.B. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med. 36:1995;1182-1190.
34. Laruelle M., Iyer R.N., al-Tikriti M.S., Zea-Ponce Y., Malison R., Zoghbi S.S., Baldwin R.M., Kung H.F., Charney D.S., Hoffer P.B., Innis R.B., Bradberry C.W. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse. 25:1997;1-14.
35. Logan J., Fowler J.S., Dewey S.L., Volkow N.D., Gatley S.J. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methylspiperone. J Neural Transm. 108:2001;279-286.
36. Lynd-Balta E., Haber S.N. The organization of midbrain projections to the striatum in the primate. sensorimotor-related striatum versus ventral striatum Neuroscience. 59:1994;625-640.
37. Marinelli M., White F.J. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci. 20:2000;8876-8885.
38. Mawlawi O., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.-R., Huang Y., Simpson N., Ngo K., Van Heertum R., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography. I Accuracy and precision of D. 2(receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21):2001;1034-1057.
39. Moore R.Y., Bloom F.E. Central catecholamine neuron systems. anatomy and physiology of the dopamine systems Annu Rev Neurosci. 1:1978;129-169.
40. Murphy D.L., Brodie H.K., Goodwin F.K., Bunney W.E. Jr. Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients. Nature. 229:1971;135-136.
41. Nurnberger J.I. Jr., Gershon E.S., Simmons S., Ebert M., Kessler L.R., Dibble E.D., Jimerson S.S., Brown G.M., Gold P., Jimerson D.C., Guroff J.J., Storch F.I. Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients. Psychoneuroendocrinology. 7:1982;163-176.
42. Paetsch P.R., Baker G.B., Caffaro L.E., Greenshaw A.J., Rauw G.A., Coutts R.T. Electron-capture gas chromatographic procedure for simultaneous determination of amphetamine and N-methylamphetamine. J Chromatogr Biomed Appl. 573:1992;313-317.
43. Piazza P.V., Deminière J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
44. Rahman S., Sahakian B.J., Cardinal R.N., Rogers R.D., Robbins T.W. Decision making and neuropsychiatry. Trends Cog Sci. 5:2001;271-277.
45. Robinson T.E., Berridge K.C. The neural basis of drug craving. an incentive-sensitization theory of addiction Brain Res Brain Res Rev. 18:1993;247-291.
46. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., Baker N.B., Hunter J., Carthy T., Booker E., London M., Deakin J.F.W., Sahakian B.J., Robbins T.W. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers. evidence for monoaminergic mechanisms Neuropsychopharmacology. 20:1999;322-339.
47. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 39:2001;32-41.
48. Sax K.W., Strakowski S.M. Enhanced behavioral response to repeated d-amphetamine and personality traits in humans. Biol Psychiatry. 44:1998;1192-1195.
49. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol. 80:1998;1-27.
50. 3H]raclopride. implications for positron emission tomography of the human brain Synapse. 3:1989;96-97.
51. Seeman P., Kapur S. Schizophrenia. more dopamine, more D2 receptors Proc Natl Acad Sci USA. 97:2000;7673-7675.
52. Sills T.L., Crawley J.N. Individual differences in sugar consumption predict amphetamine-induced dopamine overflow in nucleus accumbens. Eur J Pharmacol. 303:1996;177-181.
53. Stewart J., de Wit H., Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev. 91:1984;251-268.
54. Talairach J., Tournoux P. Co-planar Stereotactic Atlas of the Human Brain. 1988;Thieme, Stuttgart.
55. Uhlenhuth E.H., Johanson C.E., Kilgore K., Kobasa S.C. Drug preference and mood in humans. preference for d-amphetamine and subject characteristics Psychopharmacology (Berl). 74:1981;191-194.
56. Wang G.-J., Volkow N.D., Fowler J.S., Cervany P., Hitzeman R.J., Pappas N.R., Wong C.T., Felder C.T. Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci. 64:1999;775-784.
57. Willner P. Dopaminergic mechanisms in depression and mania. Bloom F.E., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress:1995;921-931 Raven Press, New York.
58. Wise R.A. Neuroleptics and operant behavior. the anhedonia hypothesis Behav Brain Sci. 5:1982;39-87.
59. Worsley K.J., Marrett S., Neelin P., Vandal A.C., Friston K.J., Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp. 4:1996;58-73.
60. Ylitalo P. Effect of exercise on pharmacokinetics. Ann Med. 23:1991;289-294.
61. Zocchi A., Orsini C., Cabib S., Puglisi-Allegra S. Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens. an in vivo study in mice Neuroscience. 82:1998;521-528.